Global In-Vitro Toxicology and Toxicity Testing Market Size, Status and Forecast 2020-2026

1 Report Overview

• 1.1 Study Scope
• 1.2 Key Market Segments
• 1.3 Market Analysis
  • 1.3.1 Global In-Vitro Toxicology and Toxicity Testing Market Size Growth Rate : 2020 VS 2026
  • 1.3.2 Cell Culture Technology
  • 1.3.3 High Throughput Technologies
  • 1.3.4 Molecular Imaging Technologies
  • 1.3.5 Omics Technologies
• 1.4 Market by Application
  • 1.4.1 Global In-Vitro Toxicology and Toxicity Testing Market Share : 2020 VS 2026
  • 1.4.2 Pharmaceutical Industry
  • 1.4.3 Chemical Industry
  • 1.4.4 Food Industry
  • 1.4.5 Other
• 1.5 Study Objectives
• 1.6 Years Considered

2 Global Growth Trends

• 2.1 Global In-Vitro Toxicology and Toxicity Testing Market Perspective (2015-2026)
• 2.2 In-Vitro Toxicology and Toxicity Testing Growth Trends by Regions
  • 2.2.1 In-Vitro Toxicology and Toxicity Testing Market Size by Regions: 2015 VS 2020 VS 2026
  • 2.2.2 In-Vitro Toxicology and Toxicity Testing Historic Market Share by Regions (2015-2020)
  • 2.2.3 In-Vitro Toxicology and Toxicity Testing Forecasted Market Size by Regions (2021-2026)
• 2.3 In-Vitro Toxicology and Toxicity Testing Industry Dynamic
  • 2.3.1 In-Vitro Toxicology and Toxicity Testing Market Trends
  • 2.3.2 In-Vitro Toxicology and Toxicity Testing Market Drivers
  • 2.3.3 In-Vitro Toxicology and Toxicity Testing Market Challenges
  • 2.3.4 In-Vitro Toxicology and Toxicity Testing Market Restraints

3 Competition Landscape by Key Players

• 3.1 Global Top In-Vitro Toxicology and Toxicity Testing Players by Market Size
  • 3.1.1 Global Top In-Vitro Toxicology and Toxicity Testing Players by Revenue (2015-2020)
  • 3.1.2 Global In-Vitro Toxicology and Toxicity Testing Revenue Market Share by Players (2015-2020)
• 3.2 Global In-Vitro Toxicology and Toxicity Testing Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
• 3.3 Players Covered: Ranking by In-Vitro Toxicology and Toxicity Testing Revenue
• 3.4 Global In-Vitro Toxicology and Toxicity Testing Market Concentration Ratio
  • 3.4.1 Global In-Vitro Toxicology and Toxicity Testing Market Concentration Ratio (CR5 and HHI)
  • 3.4.2 Global Top 10 and Top 5 Companies by In-Vitro Toxicology and Toxicity Testing Revenue in 2019
• 3.5 Key Players In-Vitro Toxicology and Toxicity Testing Area Served
• 3.6 Key Players In-Vitro Toxicology and Toxicity Testing Product Solution and Service
• 3.7 Date of Enter into In-Vitro Toxicology and Toxicity Testing Market
• 3.8 Mergers & Acquisitions, Expansion Plans

4 In-Vitro Toxicology and Toxicity Testing Breakdown Data

• 4.1 Global In-Vitro Toxicology and Toxicity Testing Historic Market Size (2015-2020)
• 4.2 Global In-Vitro Toxicology and Toxicity Testing Forecasted Market Size (2021-2026)

5 In-Vitro Toxicology and Toxicity Testing Breakdown Data

• 5.1 Global In-Vitro Toxicology and Toxicity Testing Historic Market Size (2015-2020)
• 5.2 Global In-Vitro Toxicology and Toxicity Testing Forecasted Market Size (2021-2026)

6 North America

• 6.1 North America In-Vitro Toxicology and Toxicity Testing Market Size (2015-2026)
• 6.2 North America In-Vitro Toxicology and Toxicity Testing Market Size (2015-2020)
• 6.3 North America In-Vitro Toxicology and Toxicity Testing Market Size (2015-2020)
• 6.4 North America In-Vitro Toxicology and Toxicity Testing Market Size by Country (2015-2020)
  • 6.4.1 United States
  • 6.4.2 Canada

7 Europe

• 7.1 Europe In-Vitro Toxicology and Toxicity Testing Market Size (2015-2026)
• 7.2 Europe In-Vitro Toxicology and Toxicity Testing Market Size (2015-2020)
• 7.3 Europe In-Vitro Toxicology and Toxicity Testing Market Size (2015-2020)
• 7.4 Europe In-Vitro Toxicology and Toxicity Testing Market Size by Country (2015-2020)
  • 7.4.1 Germany
  • 7.4.2 France
  • 7.4.3 U.K.
  • 7.4.4 Italy
  • 7.4.5 Russia
  • 7.4.6 Nordic

8 Asia-Pacific

• 8.1 Asia-Pacific In-Vitro Toxicology and Toxicity Testing Market Size (2015-2026)
• 8.2 Asia-Pacific In-Vitro Toxicology and Toxicity Testing Market Size (2015-2020)
• 8.3 Asia-Pacific In-Vitro Toxicology and Toxicity Testing Market Size (2015-2020)
• 8.4 Asia-Pacific In-Vitro Toxicology and Toxicity Testing Market Size by Region (2015-2020)
  • 8.4.1 China
  • 8.4.2 Japan
  • 8.4.3 South Korea
  • 8.4.4 Southeast Asia
  • 8.4.5 India
  • 8.4.6 Australia

9 Latin America

• 9.1 Latin America In-Vitro Toxicology and Toxicity Testing Market Size (2015-2026)
• 9.2 Latin America In-Vitro Toxicology and Toxicity Testing Market Size (2015-2020)
• 9.3 Latin America In-Vitro Toxicology and Toxicity Testing Market Size (2015-2020)
• 9.4 Latin America In-Vitro Toxicology and Toxicity Testing Market Size by Country (2015-2020)
  • 9.4.1 Mexico
  • 9.4.2 Brazil

10 Middle East & Africa

• 10.1 Middle East & Africa In-Vitro Toxicology and Toxicity Testing Market Size (2015-2026)
• 10.2 Middle East & Africa In-Vitro Toxicology and Toxicity Testing Market Size by Type (2015-2020)
• 10.3 Middle East & Africa In-Vitro Toxicology and Toxicity Testing Market Size by Application (2015-2020)
• 10.4 Middle East & Africa In-Vitro Toxicology and Toxicity Testing Market Size by Country (2015-2020)
  • 10.4.1 Turkey
  • 10.4.2 Saudi Arabia
  • 10.4.3 UAE

11 Key Players Profiles

• 11.1 GE Healthcare
  • 11.1.1 GE Healthcare Company Details
  • 11.1.2 GE Healthcare Business Overview
  • 11.1.3 GE Healthcare In-Vitro Toxicology and Toxicity Testing Introduction
  • 11.1.4 GE Healthcare Revenue in In-Vitro Toxicology and Toxicity Testing Business (2015-2020))
  • 11.1.5 GE Healthcare Recent Development
• 11.2 Thermo Fisher Scientific
  • 11.2.1 Thermo Fisher Scientific Company Details
  • 11.2.2 Thermo Fisher Scientific Business Overview
  • 11.2.3 Thermo Fisher Scientific In-Vitro Toxicology and Toxicity Testing Introduction
  • 11.2.4 Thermo Fisher Scientific Revenue in In-Vitro Toxicology and Toxicity Testing Business (2015-2020)
  • 11.2.5 Thermo Fisher Scientific Recent Development
• 11.3 Bio-Rad Laboratories
  • 11.3.1 Bio-Rad Laboratories Company Details
  • 11.3.2 Bio-Rad Laboratories Business Overview
  • 11.3.3 Bio-Rad Laboratories In-Vitro Toxicology and Toxicity Testing Introduction
  • 11.3.4 Bio-Rad Laboratories Revenue in In-Vitro Toxicology and Toxicity Testing Business (2015-2020)
  • 11.3.5 Bio-Rad Laboratories Recent Development
• 11.4 Agilent Technologies
  • 11.4.1 Agilent Technologies Company Details
  • 11.4.2 Agilent Technologies Business Overview
  • 11.4.3 Agilent Technologies In-Vitro Toxicology and Toxicity Testing Introduction
  • 11.4.4 Agilent Technologies Revenue in In-Vitro Toxicology and Toxicity Testing Business (2015-2020)
  • 11.4.5 Agilent Technologies Recent Development
• 11.5 Cyprotex
  • 11.5.1 Cyprotex Company Details
  • 11.5.2 Cyprotex Business Overview
  • 11.5.3 Cyprotex In-Vitro Toxicology and Toxicity Testing Introduction
  • 11.5.4 Cyprotex Revenue in In-Vitro Toxicology and Toxicity Testing Business (2015-2020)
  • 11.5.5 Cyprotex Recent Development
• 11.6 Covance
  • 11.6.1 Covance Company Details
  • 11.6.2 Covance Business Overview
  • 11.6.3 Covance In-Vitro Toxicology and Toxicity Testing Introduction
  • 11.6.4 Covance Revenue in In-Vitro Toxicology and Toxicity Testing Business (2015-2020)
  • 11.6.5 Covance Recent Development
• 11.7 Bioreliance
  • 11.7.1 Bioreliance Company Details
  • 11.7.2 Bioreliance Business Overview
  • 11.7.3 Bioreliance In-Vitro Toxicology and Toxicity Testing Introduction
  • 11.7.4 Bioreliance Revenue in In-Vitro Toxicology and Toxicity Testing Business (2015-2020)
  • 11.7.5 Bioreliance Recent Development
• 11.8 Catalent
  • 11.8.1 Catalent Company Details
  • 11.8.2 Catalent Business Overview
  • 11.8.3 Catalent In-Vitro Toxicology and Toxicity Testing Introduction
  • 11.8.4 Catalent Revenue in In-Vitro Toxicology and Toxicity Testing Business (2015-2020)
  • 11.8.5 Catalent Recent Development
• 11.9 Charles River Laboratories International
  • 11.9.1 Charles River Laboratories International Company Details
  • 11.9.2 Charles River Laboratories International Business Overview
  • 11.9.3 Charles River Laboratories International In-Vitro Toxicology and Toxicity Testing Introduction
  • 11.9.4 Charles River Laboratories International Revenue in In-Vitro Toxicology and Toxicity Testing Business (2015-2020)
  • 11.9.5 Charles River Laboratories International Recent Development
• 11.10 Alere
  • 11.10.1 Alere Company Details
  • 11.10.2 Alere Business Overview
  • 11.10.3 Alere In-Vitro Toxicology and Toxicity Testing Introduction
  • 11.10.4 Alere Revenue in In-Vitro Toxicology and Toxicity Testing Business (2015-2020)
  • 11.10.5 Alere Recent Development
• 11.11 Eurofins Scientific
  • 10.11.1 Eurofins Scientific Company Details
  • 10.11.2 Eurofins Scientific Business Overview
  • 10.11.3 Eurofins Scientific In-Vitro Toxicology and Toxicity Testing Introduction
  • 10.11.4 Eurofins Scientific Revenue in In-Vitro Toxicology and Toxicity Testing Business (2015-2020)
  • 10.11.5 Eurofins Scientific Recent Development
• 11.12 Life Technologies Corporation
  • 10.12.1 Life Technologies Corporation Company Details
  • 10.12.2 Life Technologies Corporation Business Overview
  • 10.12.3 Life Technologies Corporation In-Vitro Toxicology and Toxicity Testing Introduction
  • 10.12.4 Life Technologies Corporation Revenue in In-Vitro Toxicology and Toxicity Testing Business (2015-2020)
  • 10.12.5 Life Technologies Corporation Recent Development
• 11.13 Quest Diagnostics
  • 10.13.1 Quest Diagnostics Company Details
  • 10.13.2 Quest Diagnostics Business Overview
  • 10.13.3 Quest Diagnostics In-Vitro Toxicology and Toxicity Testing Introduction
  • 10.13.4 Quest Diagnostics Revenue in In-Vitro Toxicology and Toxicity Testing Business (2015-2020)
  • 10.13.5 Quest Diagnostics Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

• 13.1 Research Methodology
  • 13.1.1 Methodology/Research Approach
  • 13.1.2 Data Source
• 13.2 Disclaimer